-
- Huang Xiao-guang
- Department of API Research and Development, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
-
- Chen Kun-nan
- Department of API Research and Development, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
この論文をさがす
抄録
<p>Quinolone 006 is under development as an anti-methicillin-resistant Staphylococcus aureus quinolone antibiotic. A linear synthetic route was utilized to prepare the compound on a multi-kilogram scale with an overall yield of 71%. The process was optimized by controlling the temperature and the vacuum pressure. Examples of parameters examined in an effort to control the polymorphism of the 006 active pharmaceutical ingredient are described.</p>
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 67 (5), 481-486, 2019-05-01
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001288135101952
-
- NII論文ID
- 130007641160
-
- NII書誌ID
- AA00602100
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 029658563
-
- PubMed
- 31061374
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可